SCHEMBL17850338

SCHEMBL17850338

CCCCCO[C@H]1OC(COC(=O)c2ccccc2)[C@@H](OC(=O)c2ccccc2)[C@H](OC(=O)c2ccccc2)C1OC(=O)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 7/20 0.49
USP2 O75604 2/20 0.46
MEN1 O00255 1/20 0.46
POLB P06746 1/20 0.46
KMT2A Q03164 1/20 0.46
F11 P03951 2/20 0.45
TMPRSS2 O15393 1/20 0.45
PDE5A O76074 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
HMGCR P04035 1/20 0.45
CYP1A2 P05177 1/20 0.45
LCK P06239 1/20 0.45
FYN P06241 1/20 0.45
HSPD1 P10809 1/20 0.45
CYP2C9 P11712 1/20 0.45
CA6 P23280 1/20 0.45
TBXAS1 P24557 1/20 0.45
MAPK3 P27361 1/20 0.45
MAPK1 P28482 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26822757 1.00 PTPN1 (0.49) PTPN1USP2MEN1POLBKMT2A
SCHEMBL15833434 0.99 PTPN1 (0.48) PTPN1USP2MEN1POLBKMT2A
SCHEMBL16299427 0.99 PTPN1 (0.48) PTPN1USP2MEN1POLBKMT2A
SCHEMBL13447793 0.96 TSHR (0.48) PTPN1USP2MEN1POLBKMT2A
SCHEMBL17850327 0.96 TSHR (0.48) PTPN1USP2MEN1POLBKMT2A
SCHEMBL14413572 0.96 PTPN1 (0.51) PTPN1USP2MEN1POLBKMT2A
SCHEMBL23763279 0.95 PTPN1 (0.45) PTPN1USP2MEN1POLBKMT2A
SCHEMBL17850337 0.95 TSHR (0.47) PTPN1USP2MEN1POLBKMT2A
SCHEMBL9179303 0.92 PTPN1 (0.52) PTPN1USP2MEN1POLBKMT2A
SCHEMBL10273417 0.91 PTPN1 (0.44) PTPN1USP2MEN1POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3034510-A1 OLIGONUCLEOTIDES COMPRISING A C5-MODIFIED PYRIMIDINE Alnylam Pharmaceuticals Inc. (US) 2016-06-22 EP disclosed